Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism IRE1 inhibitors(Serine/threonine-protein kinase/endoribonuclease IRE1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
B-Cell Leukemia | Preclinical | US | 22 Mar 2024 | |
Multiple Myeloma | Preclinical | US | 22 Mar 2024 |